These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 27590907)

  • 1. Gender-specific growth dynamics of neurofibromatosis type-2-related tumors of the central nervous system.
    Lawson McLean A; Rosahl S
    Acta Neurochir (Wien); 2016 Nov; 158(11):2127-2134. PubMed ID: 27590907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth dynamics of intramedullary spinal tumors in patients with neurofibromatosis type 2.
    Lawson McLean AC; Rosahl SK
    Clin Neurol Neurosurg; 2016 Jul; 146():130-7. PubMed ID: 27208873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth Dynamics of Intracranial Tumors in Patients with Neurofibromatosis Type 2.
    Lawson McLean AC; Rosahl SK
    World Neurosurg; 2017 Feb; 98():152-161. PubMed ID: 27777160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric cerebellopontine angle and internal auditory canal tumors: clinical article.
    Holman MA; Schmitt WR; Carlson ML; Driscoll CL; Beatty CW; Link MJ
    J Neurosurg Pediatr; 2013 Oct; 12(4):317-24. PubMed ID: 23909617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype.
    Patronas NJ; Courcoutsakis N; Bromley CM; Katzman GL; MacCollin M; Parry DM
    Radiology; 2001 Feb; 218(2):434-42. PubMed ID: 11161159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal tumors in neurofibromatosis type 2. Is emerging knowledge of genotype predictive of natural history?
    Dow G; Biggs N; Evans G; Gillespie J; Ramsden R; King A
    J Neurosurg Spine; 2005 May; 2(5):574-9. PubMed ID: 15945431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients.
    Plotkin SR; O'Donnell CC; Curry WT; Bove CM; MacCollin M; Nunes FP
    J Neurosurg Spine; 2011 Apr; 14(4):543-7. PubMed ID: 21294614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracranial meningiomas and neurofibromatosis type 2.
    Aboukais R; Zairi F; Baroncini M; Bonne NX; Schapira S; Vincent C; Lejeune JP
    Acta Neurochir (Wien); 2013 Jun; 155(6):997-1001; discussion 1001. PubMed ID: 23558725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term growth rate of vestibular schwannoma in neurofibromatosis 2: A volumetric consideration.
    Picry A; Bonne NX; Ding J; Aboukais R; Lejeune JP; Baroncini M; Dubrulle F; Vincent C
    Laryngoscope; 2016 Oct; 126(10):2358-62. PubMed ID: 27075822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D Volumetric Measurement of Neurofibromatosis Type 2-Associated Meningiomas: Association Between Tumor Location and Growth Rate.
    Evers S; Verbaan D; Sanchez E; Peerdeman S
    World Neurosurg; 2015 Oct; 84(4):1062-9. PubMed ID: 26087434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
    Seppälä MT; Sainio MA; Haltia MJ; Kinnunen JJ; Setälä KH; Jääskeläinen JE
    J Neurosurg; 1998 Jul; 89(1):36-41. PubMed ID: 9647170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramedullary tumours in patients with neurofibromatosis type 2: MRI features associated with a favourable prognosis.
    Rennie AT; Side L; Kerr RS; Anslow P; Pretorius P
    Clin Radiol; 2008 Feb; 63(2):193-200. PubMed ID: 18194696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety.
    Mautner VF; Tatagiba M; Lindenau M; Fünsterer C; Pulst SM; Baser ME; Kluwe L; Zanella FE
    AJR Am J Roentgenol; 1995 Oct; 165(4):951-5. PubMed ID: 7676998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2.
    Abaza MM; Makariou E; Armstrong M; Lalwani AK
    Laryngoscope; 1996 Jun; 106(6):694-9. PubMed ID: 8656953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of spinal tumors in neurofibromatosis type 2 patients.
    Nowak A; Dziedzic T; Czernicki T; Kunert P; Marchel A
    Neurol Neurochir Pol; 2016; 50(1):31-5. PubMed ID: 26851687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vestibular schwannoma growth in patients with neurofibromatosis Type 2: a longitudinal study.
    Mautner VF; Baser ME; Thakkar SD; Feigen UM; Friedman JM; Kluwe L
    J Neurosurg; 2002 Feb; 96(2):223-8. PubMed ID: 11838794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
    Plotkin SR; Merker VL; Halpin C; Jennings D; McKenna MJ; Harris GJ; Barker FG
    Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the growth rate of vestibular schwannoma in patients with neurofibromatosis type 2.
    Li H; Hao SY; Wang L; Li D; Wu Z; Zhang LW; Zhang JT
    Acta Neurochir (Wien); 2015 Nov; 157(11):1983-90. PubMed ID: 26287269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.